167 related articles for article (PubMed ID: 36531826)
1. Ethionamide and Prothionamide Based Coumarinyl-Thiazole Derivatives: Synthesis, Antitubercular Activity, Toxicity Investigations and Molecular Docking Studies.
Imran M
Pharm Chem J; 2022; 56(9):1215-1225. PubMed ID: 36531826
[TBL] [Abstract][Full Text] [Related]
2.
Bakale RD; Phatak PS; Rathod SS; Choudhari PB; Rekha EM; Sriram D; Kulkarni RS; Haval KP
J Biomol Struct Dyn; 2023 Dec; ():1-20. PubMed ID: 38079301
[TBL] [Abstract][Full Text] [Related]
3. Discovery of 1,2,3-triazole incorporated indole-piperazines as potent antitubercular agents: Design, synthesis, in vitro biological evaluation, molecular docking and ADME studies.
Reddyrajula R; Etikyala U; Manga V; Kumar Dalimba U
Bioorg Med Chem; 2024 Jan; 98():117562. PubMed ID: 38184947
[TBL] [Abstract][Full Text] [Related]
4. A review of the use of ethionamide and prothionamide in childhood tuberculosis.
Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS
Tuberculosis (Edinb); 2016 Mar; 97():126-36. PubMed ID: 26586647
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, In silico and Biological Studies of Thiazolyl-2h-chromen-2-one Derivatives as Potent Antitubercular Agents.
Jadhav BS; Yamgar RS; Kenny RS; Mali SN; Chaudhari HK; Mandewale MC
Curr Comput Aided Drug Des; 2020; 16(5):511-522. PubMed ID: 31438831
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-
Venugopala KN; Uppar V; Chandrashekharappa S; Abdallah HH; Pillay M; Deb PK; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Tratrat C; Yousef Jaber A; Venugopala R; Mailavaram RP; Al-Jaidi BA; Kandeel M; Haroun M; Padmashali B
Antibiotics (Basel); 2020 May; 9(5):. PubMed ID: 32392709
[TBL] [Abstract][Full Text] [Related]
7. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study.
Venugopala KN; Deb PK; Pillay M; Chopra D; Chandrashekharappa S; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Kandeel M; Venugopala R; Mohanlall V
Curr Top Med Chem; 2021; 21(4):295-306. PubMed ID: 33138763
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro, and in vivo (Zebra fish) antitubercular activity of 7,8-dihydroquinolin-5(6H)-ylidenehydrazinecarbothioamides.
Marvadi SK; Krishna VS; Surineni G; Srilakshmi Reshma R; Sridhar B; Sriram D; Kantevari S
Bioorg Chem; 2020 Mar; 96():103626. PubMed ID: 32007719
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and antitubercular assessment of 1, 2, 3-triazole incorporated thiazolylcarboxylate derivatives.
Bakale RD; Sulakhe SM; Kasare SL; Sathe BP; Rathod SS; Choudhari PB; Madhu Rekha E; Sriram D; Haval KP
Bioorg Med Chem Lett; 2024 Jan; 97():129551. PubMed ID: 37979730
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, anticancer activity and docking studies of novel quinazoline-based thiazole derivatives as EGFR kinase inhibitors.
Raghu MS; Swarup HA; Shamala T; Prathibha BS; Kumar KY; Alharethy F; Prashanth MK; Jeon BH
Heliyon; 2023 Sep; 9(9):e20300. PubMed ID: 37809937
[TBL] [Abstract][Full Text] [Related]
11. 5-Oxo-dihydropyranopyran derivatives as anti-proliferative agents; synthesis, biological evaluation, molecular docking, MD simulation, DFT, and
Ranjbar S; Sadeghian P; Khademian S; Emami M; Jahromi ZP; Mirmajidi SH; Zare F; Negahdaripour M; Ghasemi Y; Khoshneviszadeh M
Heliyon; 2024 May; 10(9):e29850. PubMed ID: 38707385
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel furan-based chalcone derivatives as anti-tuberculosis agents:
Dhivya LS; Kumaradoss KM
Future Med Chem; 2023 Sep; 15(18):1687-1701. PubMed ID: 37732414
[No Abstract] [Full Text] [Related]
13. Antitubercular activity of new coumarins.
Cardoso SH; Barreto MB; Lourenço MC; Henriques Md; Candéa AL; Kaiser CR; de Souza MV
Chem Biol Drug Des; 2011 Jun; 77(6):489-93. PubMed ID: 21414146
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.
Alegaon SG; Alagawadi KR; Dadwe DH
Drug Res (Stuttg); 2014 Oct; 64(10):553-8. PubMed ID: 24446205
[TBL] [Abstract][Full Text] [Related]
15. New coumarin linked thiazole derivatives as antimycobacterial agents: Design, synthesis, enoyl acyl carrier protein reductase (InhA) inhibition and molecular modeling.
Kassem AF; Sabt A; Korycka-Machala M; Shaldam MA; Kawka M; Dziadek B; Kuzioła M; Dziadek J; Batran RZ
Bioorg Chem; 2024 May; 150():107511. PubMed ID: 38870705
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-Mycobacterium tuberculosis activity of imide-β-carboline and carbomethoxy-β-carboline derivatives.
Lopes-Ortiz MA; Panice MR; Borges de Melo E; Ataide Martins JP; Baldin VP; Agostinho Pires CT; Caleffi-Ferracioli KR; Dias Siqueira VL; Bertin de Lima Scodro R; Sarragiotto MH; Cardoso RF
Eur J Med Chem; 2020 Feb; 187():111935. PubMed ID: 31816556
[TBL] [Abstract][Full Text] [Related]
17. New INH-pyrazole analogs: Design, synthesis and evaluation of antitubercular and antibacterial activity.
Nayak N; Ramprasad J; Dalimba U
Bioorg Med Chem Lett; 2015 Dec; 25(23):5540-5. PubMed ID: 26520663
[TBL] [Abstract][Full Text] [Related]
18. Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme.
Venugopala KN; Chandrashekharappa S; Deb PK; Tratrat C; Pillay M; Chopra D; Al-Shar'i NA; Hourani W; Dahabiyeh LA; Borah P; Nagdeve RD; Nayak SK; Padmashali B; Morsy MA; Aldhubiab BE; Attimarad M; Nair AB; Sreeharsha N; Haroun M; Shashikanth S; Mohanlall V; Mailavaram R
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1472-1487. PubMed ID: 34210233
[TBL] [Abstract][Full Text] [Related]
19. Potential Fluorinated Anti-MRSA Thiazolidinone Derivatives with Antibacterial, Antitubercular Activity and Molecular Docking Studies.
Kumar V; Shetty P; H S A; Chandra K S; Ramu R; Patil SM; Baliga A; Rai VM; M SS; Udupi V; Poojary V; Poojary B
Chem Biodivers; 2022 Feb; 19(2):e202100532. PubMed ID: 34929067
[TBL] [Abstract][Full Text] [Related]
20. Molecular explorations of substituted 2-(4-phenylquinolin-2-yl) phenols as phosphoinositide 3-kinase inhibitors and anticancer agents.
Alagumuthu M; Arumugam S
Cancer Chemother Pharmacol; 2017 Feb; 79(2):389-397. PubMed ID: 28054203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
